Articles related to Dermatology

PORT is recommended for patients with cSCC having close or positive margins that cannot be corrected with further surgery (secondary to morbidity or adverse cosmetic outcome). In patients with cSCC, PORT is recommended for T3 and T4 tumors—both strong recommendations with moderate to low evidence quality.

Patients taking GLP-1 receptor agonists lose an average of 7 percent of their facial volume for every 22 pounds lost, mostly from fat pads in the midface—yet clinical trials rarely report facial fat loss as an adverse effect, leaving providers unlikely to counsel patients pretreatment about undesirable facial appearance changes.

“These results would really shift our practice from starting it once patients have developed numerous skin cancers to starting it earlier. We still need to do a better job of identifying who will actually benefit, as roughly only half of patients will develop multiple skin cancers.” – Lee Wheless, MD, PhD

“Lidocaine is not as safe as we think… there is underreporting. I cannot predict an upper limit of the increase.” – Dr. Michael Fettiplace

Studies have found that parabens mimic estrogen in the body and disrupt normal hormone function, and they have been found in breast-tumor biopsies.

“Candida yeast infections are frequent beneath the breast… The yeast enjoys dark, wet environments. If not cleaned, bras might worsen them.” – Dr. Leah Ansell, Dermatologist